title: Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study.
abstract: Recently, artemisinin derivatives have been shown to be efficacious in chemoprophylaxis of and chemotherapy for Schistosoma japonicum and S. mansoni infections. Therefore, a double-blind, randomized, placebo-controlled study was carried out to investigate the efficacy and tolerability of artesunate plus placebo and the combination of artesunate and praziquantel in the treatment of S. haematobium infections in Gabon. The 300 infected schoolchildren included in the study were randomized to receive artesunate plus placebo (n=90), praziquantel plus placebo (n=90), artesunate and praziquantel (n=90), or only placebo (n=30). End points were efficacy, assessed as cure on day 56, and tolerability. All treatment regimens were well tolerated. The praziquantel plus placebo-treated group attained a cure rate of 73%, artesunate plus placebo a rate of 27%, the combination of artesunate and praziquantel a rate of 81%, and placebo alone a rate of 20%. In summary, earlier findings of efficacy of artemisinin derivitives against S. mansoni and S. japonicum could not be confirmed in S. haematobium infections.
authors.affiliation: Department of Parasitology, Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany. steffen.borrmann@uni-tuebingen.de
authors.forename: S
authors.initials: S
authors.lastname: Borrmann
authors.forename: N
authors.initials: N
authors.lastname: Szlezák
authors.forename: J F
authors.initials: JF
authors.lastname: Faucher
authors.forename: P B
authors.initials: PB
authors.lastname: Matsiegui
authors.forename: R
authors.initials: R
authors.lastname: Neubauer
authors.forename: R K
authors.initials: RK
authors.lastname: Binder
authors.forename: B
authors.initials: B
authors.lastname: Lell
authors.forename: P G
authors.initials: PG
authors.lastname: Kremsner
mesh_terms: D000818:Animals; D000871:Anthelmintics / Q000627:therapeutic use*; D037621:Artemisinins; D000077332:Artesunate; D002648:Child; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D005681:Gabon; D006801:Humans; D008297:Male; D010919:Placebos; D011223:Praziquantel / Q000627:therapeutic use*; D012548:Schistosoma haematobium; D012553:Schistosomiasis haematobia / Q000188:drug therapy*; D012717:Sesquiterpenes / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000871:Anthelmintics; D037621:Artemisinins; D010919:Placebos; D012717:Sesquiterpenes; D000077332:Artesunate; D011223:Praziquantel